Enhancing antimicrobial management: A 5-year retrospective analysis of urinary pathogen susceptibility at a tertiary care centre from January 2018 to December 2022

Abstract

Objective: The study aims to collect data on prevalence and antibiotic susceptibility patterns of uropathogens in a hospital in India, and to analyze any changes that have occurred over the past 5 years.
Methods: This retrospective study was conducted over 5 years at Lady Hardinge Medical College & Associated Hospitals, New Delhi. Urine samples from patients who attended outpatient department or were admitted with diagnosis of urinary tract infection (UTI) were included in this study. Samples were cultured and tested to identify bacteria and determine antibiotic susceptibility using the Kirby-Bauer disc diffusion method.
Results: A total of number of 151 395 urine specimens were collected from January 2018 to December 2022. The prevalence of UTI was 7.5% (11 372/151 395) with the majority of patients being aged above 40 years (19.3%). The prevalence was higher in females (12.7%) as compared to males (3.2%). Escherichia coli was the predominant pathogen, accounting for 59.8% of cases, followed by Klebsiella spp. at 18.9%, and Enterococcus spp. at 8.3%. Gram-negative bacteria accounted for 89.5% of the isolates and exhibited good susceptibility to aminoglycosides and piperacillin-tazobactam, but showed resistance to fluoroquinolones. Methicillin-resistant Staphylococcus aureus (MRSA) was present in 35% of Staphylococcus aureus isolates with high susceptibility to glycopeptides and nitrofurantoin.
Conclusions: The data suggest the need for careful selection of empirical therapy due to increasing resistance patterns. The stringent use of antimicrobial agents is pivotal to the control of antimicrobial resistance. Antibiotic susceptibility data contributes to tailoring the antibiotic stewardship programs to local needs.

Keywords

Urinary tract infection / Extended-spectrum beta-lactamase / Resistance / Antibiotic susceptibility testing

Conflict of interest statement

The authors declare that there is no conflict of interest.

Funding

This study received no extramural funding.

Data availability statement

The data supporting the findings of this study are available from the corresponding author upon request.

Authors’ contributions

William A prepared and revised the manuscript. Rawat D supervised, checked corrections and revised the manuscript. Satija S supervised and revised the manuscript. Kaur R supervised and checked corrections in the manuscript.

References

[1] Vasudevan R. Urinary tract infection: An overview of the infection and the associated risks factors. J Microbiol Exp 2014; 1(2): 42-54.

[2] Minardi D, d’Anzeo G, Cantoro D, Conti A, Muzzonigro G. Urinary tract infections in women: Etiology and treatment options. Int J Gen Med 2011; 4: 333-343.

[3] Mody L, Juthani-Mehta M. Urinary tract infections in older women: A clinical review. JAMA 2014; 311(8): 844-854.

[4] Vigila CR, Athinarayanan G, Mariselvam R, Dhasarathan P, Ranjit singh AJA . Epidemiology of urinary tract infection in South India. World J Biol Pharm Health Sci 2020; 1(1): 25-32.

[5] Foxman B, Brown P. Epidemiology of urinary tract infections: Transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 2003; 17(2): 227-241.

[6] Nicolle LE, AMMI Canada Guidelines Committee . Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol 2005; 16(6): 349-360.

[7] Eshwarappa M, Dosegowda R, Aprameya IV, Khan MW, Kumar PS, Kempegowda P. Clinico-microbiological profile of urinary tract infection in south India. Indian J Nephrol 2011; 21(1): 30-36.

[8] Alós JI. Epidemiology and etiology of urinary tract infections in the community. Antimicrobial susceptibility of the main pathogens and clinical significance of resistance. Enferm Infecc Microbiol Clin 2005; 23(Suppl 4): 3-8.

[9] Collee JG, Miles RS, Watt B. Tests for the identification of bacteria. London: Churchill Livingstone (UK); 1996, p. 433.

[10] Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: Self-reported incidence and associated costs. Annals Epidemiol 2000; 10(8): 509-515.

[11] Andreua A, Alós JI, Gobernado M, Marco F, De La Rosa M, García-Rodríguez JA . Etiology and antimicrobial susceptibility among uropathogens causing community-acquired lower urinary tract infections: A nationwide surveillance study. Enferm Infecc Microbiol Clin 2005; 23(1): 4-9.

[12] Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45(4): 493-496.

[13] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA. 2006. [Online] Available from: https://clsi.org/standards/products/microbiology/documents/m100/. [Accessed on 6 November 2022].

[14] Bigwan EI, Elijah D. Prevalence of Escherichia coli among uropathogens in asymptomatic bacteriuria in a Nigerian Tertiary School in Jos, Nigeria . Int J Biomed Adv Res 2013; 4(3): 198-202.

[15] Jain S, Sharma M, Kumar M, Shree N, Sharma Y. Prevalence of uropathogens in urinary tract infection and their antimicrobial resistance pattern in a North Delhi hospital, India: A Nine Year Study. Int J Microbiol Res 2014; 6(1): 545-552.

[16] Schaeffer AJ, Rajan N, Cao Q, Anderson BE, Pruden DL, Sensibar J, et al. Host pathogenesis in urinary tract infections. Int J Antimicrob Agents 2001; 17(4): 245-251.

[17] Rajalakshmi V, Amsaveni V. Antibiotic susceptibility of bacterial pathogens isolated from diabetic patients. Int J Microbiol Res 2012; 3(1): 30-32.

[18] Orrett FA. Urinary tract infections in general practice in a rural community in South Trinidad. Saudi Med J 2001; 22(6): 537-540.

[19] Shigemura K, Tanaka K, Okada H, Nakano Y, Kinoshita S, Gotoh A, et al. Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan. Jpn J Infect Dis 2005; 58(5): 303-308.

[20] Das RN, Chandrashekhar TS, Joshi HS, Gurung M, Shrestha N, Shivananda PG. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal. Singapore Med J 2006; 47(4): 281-285.

[21] Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK, Durowade K, Kolawole CF. Prevalence of urinary tract infections (UTI) among patients attending DalhatuAraf Specialist Hospital, Lafia, Nasarawa State, Nigeria. Int J Med Med Sci 2009; 1(5): 163-167.

[22] Storme O, Tirán Saucedo J, Garcia-Mora A, Dehesa-Dávila M, Naber KG. Risk factors and predisposing conditions for urinary tract infection. Ther Adv Urol 2019; 11: 1756287218814382.

[23] Dimitrov TS, Udo EE, Awni F, Emara M, Passadilla R. Etiology and antibiotic susceptibility patterns of community-acquired urinary tract Infections in a Kuwait Hospital. Med Princ Pract 2004; 13(6): 334-339.

[24] Omigie O, Okoror L, Umolu P, Ikuuh G. Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens. Int J Gen Med 2009; 2: 171-175.

[25] Dash M, Padhi S, Mohanty I, Panda P, Parida B. Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odisha, India. J Fam Community Med 2013; 20(1): 20-26.

[26] Yigit Y, Yazici V, Ayhan H, et al. The analysis of Escherichia coli resistance in urine culture and in antibiograms as requested by emergency service . Turk J Emerg Med 2016; 14(3): 121-124.

[27] Haghi-Ashteiani M, Sadeghifard N, Abedini M, Soroush S, Taheri-Kalani M. Etiology and antibacterial resistance of bacterial urinary tract infections in children’s medical center, Tehran, Iran. Acta Med Iran 2007; 45(2): 153-157.

[28] Kaur N, Sharma S, Malhotra S, Madan P, Hans C. Urinary tract infection: Aetiology and antimicrobial resistance pattern in infants from a tertiary care hospital in northern India. J Clin Diagn Res 2014; 8(10): DC01-3.

[29] Onanuga A, Awhowho GO. Antimicrobial resistance of Staphylococcus aureus strains from patients with urinary tract infections in Yenagoa, Nigeria . J Pharm Bioallied Sci 2012; 4(3): 226-230.

[30] Patil SS, Suresh KP, Shinduja R, et al. Prevalence of methicillin-resistant Staphylococcus aureus in India: A systematic review and meta-analysis . Oman Med J 2022; 37(4): e440.

[31] Looney AT, Redmond EJ, Davey NM, Daly PJ, Troy C, Carey BF, et al. Methicillin-resistant Staphylococcus aureus as a uropathogen in an Irish setting . Medicine (Baltimore) 2017; 96(14): e4635.

[32] Smout E, Palanisamy N, Valappil SP. Prevalence of vancomycin-resistant Enterococci in India between 2000 and 2022: A systematic review and meta-analysis . Antimicrob Resist Infect Control 2023; 12(1): 79.